KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Enterprise Value: 2018-2025

Historic Enterprise Value for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to $1.1 billion.

  • Aurinia Pharmaceuticals' Enterprise Value rose 57.67% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $116.2 million, marking a year-over-year increase of 138.54%. This contributed to the annual value of $927.3 million for FY2024, which is 1.41% down from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Enterprise Value is $1.1 billion, which was up 32.98% from $829.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Enterprise Value registered a high of $2.6 billion during Q3 2021, and its lowest value of $224.5 million during Q4 2022.
  • Over the past 3 years, Aurinia Pharmaceuticals' median Enterprise Value value was $829.2 million (recorded in 2025), while the average stood at $835.7 million.
  • In the last 5 years, Aurinia Pharmaceuticals' Enterprise Value slumped by 82.41% in 2022 and then soared by 318.91% in 2023.
  • Aurinia Pharmaceuticals' Enterprise Value (Quarterly) stood at $1.3 billion in 2021, then slumped by 82.41% to $224.5 million in 2022, then surged by 318.91% to $940.5 million in 2023, then dropped by 1.41% to $927.3 million in 2024, then skyrocketed by 57.67% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $829.2 million for Q2 2025, and $791.3 million during Q1 2025.